Profound Medical (PROF) Net Cash Flow (2024 - 2026)

Profound Medical's Net Cash Flow history runs 3 years deep, the most recent figure standing at -$8.6 million for Q1 2026.

• In Q1 2026, Net Cash Flow changed 0.12% year-over-year to -$8.6 million; the TTM figure through Mar 2026 stood at $2.9 million (down 56.68% YoY), while the FY2025 annual figure was $2.7 million, down 91.39% from the prior year.
• Net Cash Flow was -$8.6 million for Q1 2026 at Profound Medical, down from $34.9 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $34.9 million in Q4 2025 to a low of -$13.7 million in Q2 2025.
• Historically, Net Cash Flow has averaged $2.8 million across 3 years, with a median of -$7.4 million in 2024.
• Biggest YoY gain for Net Cash Flow was 17.95% in 2025; the steepest drop was 153.83% in 2025.
• A 3-year view of Net Cash Flow shows it stood at $29.6 million in 2024, then increased by 17.95% to $34.9 million in 2025, then plunged by 124.62% to -$8.6 million in 2026.
• The last three Net Cash Flow figures came in at -$8.6 million (Q1 2026), $34.9 million (Q4 2025), and -$9.6 million (Q3 2025), per Business Quant data.